PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Implementations can drastically impact overall satisfaction with a pharmacy benefit manager (PBM). Here are focused insights on how satisfied plans were with their PBM implementations.
NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor Improved oversight of PBM rebates via Artemetrx Rebate Monitor protects the financial interests of health…
Would you be surprised to learn specialty drug trend slowed in 2020 compared to recent years? Unfortunately, we know that the pandemic likely impacted trend…
CVS Health (CVS) announced their 2022 formulary changes, both exclusions and additions, stating the focus of their formulary strategy continues to be “providing access to…
In recent weeks, Express Scripts (ESI) released their list of January 1, 2022 formulary changes for their National Preferred Formulary and National Preferred Flex Formulary.
Specialty trend increasing at a slower pace but maintains double-digit growth in PSG’s fifth annual integrated pharmacy and medical benefit report DALLAS, Tex. – Pharmaceutical…
The FDA approval of Aduhelm on June 7, 2021, sparked both concern and confusion among stakeholders. There was skepticism that patients in all stages of…
Newly published peer-reviewed research in the Journal of Occupational and Environmental Medicine found that companies with a culture of health outperform the stock market (as expressed by…
Results of comprehensive PBM customer satisfaction research released by Pharmaceutical Strategies Group PSG’s Pharmacy Benefit Manager (PBM) Customer Satisfaction report explores more than 40 dimensions…
